Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04952870

Perinatal Covid-19 Infection, NO Pathway, and Minipuberty

Sponsor: University Hospital, Lille

View on ClinicalTrials.gov

Summary

Some evidence exists that SARS-COV-2 may infect pituitary axis, and therefore may alter hypothalamic function. Whether perinatal COVID-19 is associated with alterations in the maturation of the Hypothalamic-Pituitary-Gonadal (HPG) axis, and specifically with its transient activation occurring during infancy, namely minipuberty, is a major concern. Among the various pathogenic features related to COVID-19, altered minipuberty could be a key factor underlying many multimorbidities later in life, suggesting that they could involve a common causative mechanism that occurs within this short and critical period of time following birth. Altered minipuberty together with NO deficiency seem to be key factors underlying many of these multimorbidities, suggesting that they involve a common causative mechanism that occurs within this short and critical period of time following birth

Official title: Exploratory Multicenter Observational Study to Assess the Outcome of Infants With Perinatal SARS-COV-2 Infection and Its Link With the NO Pathway: the Minipuberty Hypothesis

Key Details

Gender

All

Age Range

Any - 3 Months

Study Type

OBSERVATIONAL

Enrollment

180

Start Date

2022-11-03

Completion Date

2026-11

Last Updated

2023-02-08

Healthy Volunteers

No

Interventions

OTHER

Inhaled NO

Newborn or young infants (\< 3 months) receiving inhaled NO as part of their treatment for severe respiratory failure

OTHER

routine care

Patients treated for respiratory failure

Locations (2)

Hop Jeanne de Flandre Chu Lille

Lille, France

Uri-National and Kapodistrian University of Athens

Athens, Greece